Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q2 2023 Earnings Call Transcript August 3, 2023
Lexicon Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.22 EPS, expectations were $0.17.
Operator: Good day, and welcome to the Lexicon Pharmaceuticals Second Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions]...
